9 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... LAMA: long-acting ... #Management #Pulmonary ... COPD #GOLD2017 #LAMA
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
-agonist; LAMA, ... #Algorithm #Management ... #Pulmonary #LABA ... #LAMA #SABA #SAMA ... #ICS #Pharmacology
There is a hydropneumothorax.
Notice the air-fluid level (blue arrow).
The upper lobe is still attached to the
lymphangioleiomyomatosis (LAM ... LAM is a rare lung ... to pulmonary cyst ... LAM also occurs ... Lymphangioleiomyomatosis #LAM
There is a hydropneumothorax.
Notice the air-fluid level.
The upper lobe is still attached to the chest wall
lymphangioleiomyomatosis (LAM ... LAM is a rare lung ... to pulmonary cyst ... LAM also occurs ... Lymphangioleiomyomatosis #LAM
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
• Large volume feeding ... Blood cultures • CXR ... early disease) • CXR ... upright or lat ... #Abscess #pulmonary
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
involvement - seeding ... and Culture • CXR ... disease • Check CXR ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
involvement - seeding ... and Culture • CXR ... disease • Check CXR ... TB #Diagnosis #Management ... #Treatment #ActiveTB
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... is vital while lab ... #differential #algorithm ... #management #cardiology ... icu #clinical #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
, INC risk PE, Pulmonary ... MALT Lymphoma • Lung ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management